Related Experiment Video
Updated: May 15, 2025

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
Mechanisms underlying altered ubiquitin-proteasome system activity during heart failure and pharmacological
Xiaofei Gao1, Yu Cao2, Hangyan Li3
1Department of Cardiology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, 310006, Zhejiang, China.
Insights
The ubiquitin-proteasome system (UPS) is crucial for heart health. Dysregulation of this protein degradation pathway contributes to heart failure (HF), offering new therapeutic targets.
Area of Science:
- Cardiovascular Science
- Molecular Biology
- Biochemistry
Background:
- Heart failure (HF) is a growing global health concern with complex, incompletely understood causes.
- Protein turnover is vital for cardiac homeostasis; impaired protein degradation systems are implicated in heart disease.
- The ubiquitin-proteasome system (UPS) regulates cardiac cell structure and function through protein degradation.
Purpose of the Study:
- To review the mechanisms of altered UPS activity in heart failure.
- To outline UPS regulators influencing HF progression.
- To discuss the therapeutic potential of small molecules targeting UPS in HF.
Main Methods:
- Literature review focusing on the role of the UPS in cardiovascular physiology and pathophysiology.
- Analysis of research on UPS dysregulation in the context of heart failure.
- Synthesis of findings on UPS regulators and small molecule interventions.
Main Results:
- The UPS plays a significant role in cardiac homeostasis and its dysregulation is linked to heart failure.
- Several UPS components and regulators have been identified as key players in HF progression.
- Novel therapeutic strategies targeting the UPS for HF treatment are emerging.
Conclusions:
- Understanding UPS alterations in HF is essential for developing targeted therapies.
- The UPS represents a promising target for pharmacological intervention in heart failure.
- Small molecules offer potential for modulating UPS function to treat HF.
Abstract:
Heart failure (HF) is a refractory disease with a global prevalence that is continuously increasing. The mechanisms underlying the pathogenesis of HF are multi-faceted, intricate, and not yet fully elucidated. Appropriate levels of protein turnover are essential for maintaining cardiac homeostasis and, accordingly, compromised protein degradation systems can significantly contribute to heart disease. The ubiquitin-proteasome system (UPS) modulates the structure and function of cardiac cells by facilitating the degradation of signaling and structural proteins. Research in the preceding decade has focused on elucidating the role of the UPS in the context of cardiovascular physiology and pathophysiology. A comprehensive understanding of the UPS status and the underlying mechanisms contributing to its potential dysregulation in HF is imperative for developing targeted therapeutic interventions. Previous research has identified several novel interventions involving components of the UPS and several have been adapted for HF therapy. In this review, we summarize the mechanisms underlying altered UPS activity in HF and provide an outline of UPS regulators that affect the progression of HF. Additionally, the potential for small molecules to intervene in UPS function in HF is discussed.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pathophysiology of Heart Failure
Heart Failure Drugs: Diuretics
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Inotropic Agents
Pathophysiology of Cardiac Performance

